Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

paxvax ltd. - salmonella typhi stamme ty 21a berna, frysetørret (levende) - enterokapsler, hårde - 2 mia bakterier

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - salmonella typhi stamme ty 21a berna, frysetørret (levende) - enterokapsler, hårde - 2 mia bakterier

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bavarian nordic a/s - salmonella typhi stamme ty 21a berna, frysetørret (levende) - enterokapsler, hårde - 2 mia. bakterier

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited  - lutetium (177lu) vipivotide tetraxetan - prostatic neoplasmer, kastration-resistent - terapeutiske radioaktive lægemidler - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

gedeon richter plc. - perindopril tert-butylamin - tabletter - 4 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

gedeon richter plc. - perindopril tert-butylamin - tabletter - 8 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionuklidbilleddannelse - diagnostiske radioaktive lægemidler - dette lægemiddel er kun til diagnostisk brug. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

evolan pharma ab - adenosin - injektions-/infusionsvæske, opløsning - 5 mg/ml